Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $193.9950 (18.44%) ($193.9950 - $195.1850) on Thu. Jan. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.76% (three month average) | RSI | 98 | Latest Price | $193.9950(18.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 7.8% a day on average for past five trading days. | Weekly Trend | LGND advances 22.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.88% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-15%) UNG(-3%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.88% (StdDev 3.76%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $162.55(19.34%) | 10 Day Moving Average | $147.14(31.84%) | 20 Day Moving Average | $126.93(52.84%) | To recent high | 0% | To recent low | 138.3% | Market Cap | $3.118b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |